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Abstract 
In pancreatic beta cells, mitochondrial bioenergetics control glucose-stimulated 
insulin secretion (GSIS). Mitochondrial dynamics are generally associated with 
quality control, maintaining the functionality of bioenergetics. By acute 
pharmacological inhibition of mitochondrial fission protein Drp1, we here 
demonstrate that mitochondrial fission is necessary for GSIS in mouse and human 
islets. We confirm that genetic silencing of Drp1 increases mitochondrial proton leak 
in MIN6 cells. However, our comprehensive analysis of pancreatic islet bioenergetics 
reveals that Drp1 does not control insulin secretion via its effect on proton leak but 
instead via modulation of glucose-fuelled respiration. Notably, pyruvate fully rescues 
the impaired insulin secretion of fission-deficient beta cells, demonstrating that 
defective mitochondrial dynamics solely impact substrate supply upstream of 
oxidative phosphorylation. The present findings provide novel insights in how 
mitochondrial dysfunction may cause pancreatic beta cell failure. In addition, the 
results will stimulate new thinking in the intersecting fields of mitochondrial 
dynamics and bioenergetics, as treatment of defective dynamics in mitochondrial 
diseases appears to be possible by improving metabolism upstream of mitochondria.  
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The development of type-2 diabetes mellitus is associated with mitochondrial 
dysfunction in pancreatic beta-(β)-cells. β-cells have developed highly coordinated 
mechanisms that link glucose sensing with metabolic signaling cascades that direct 
the secretion of sufficient insulin to maintain glucose homeostasis [1]. The 
mechanism underlying glucose-stimulated insulin secretion (GSIS) from β-cells 
involves glucose uptake by specific glucose transporters followed by glucose 
catabolism through glycolysis yielding pyruvate, which in turn is further catabolized 
via the tricarboxylic (TCA) cycle. Both glycolysis and TCA-cycle turnover generate 
reducing power that is used by the mitochondrial respiratory chain to produce ATP 
through oxidative phosphorylation. The resultant increase in the cytosolic ATP/ADP 
ratio closes ATP-sensitive K+ (KATP) channels, thus depolarizing the plasma 
membrane. Depolarization triggers opening of voltage-gated Ca2+ channels, and the 
influx of Ca2+ ions consequently leads to exocytosis of insulin-containing granules 
from β-cells [2]. This sequence of events illustrates that β-cell mitochondria exert 
strong control over GSIS [3] as mitochondrial energy-transducing processes dictate 
how fast and efficiently glucose is converted to ATP. Mitochondrial dysfunction 
impairs glucose-insulin secretion coupling and ultimately promotes β-cell apoptosis 
and death, one of the key features of type-2 diabetes (T2D) [4]. 
Mitochondria are dynamic organelles that are constantly remodeled through 
the opposing action of fission and fusion proteins [5]. Until recently, the influence of 
mitochondrial dynamics over energy transduction has been under-appreciated. The 
continuous changes in mitochondrial morphology are controlled by a group of 
evolutionarily highly-conserved large GTPases of the dynamin superfamily [5]. 
Mitochondrial fusion is regulated by mitofusins 1 and 2 (Mfn1/2) and optic-atrophy 1 
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(Opa1), whereas mitochondrial fission is regulated by dynamin-related protein 1 
(Drp1) and fission protein 1 (Fis1) [6]. Increasing evidence suggests that a subtle 
balance between mitochondrial fission and fusion events is crucial for achieving the 
mitochondrial morphology required for a particular (energetic) function [7-9]. 
Deficiencies in the proteins regulating mitochondrial dynamics have been associated 
with several human diseases including dominant Optic Atrophy for Opa1, Charcot-
Marie-Tooth disease type 2A for Mfn2, and developmental defects for Drp1 [10-12]. 
Indeed, there is evidence that the pancreatic islets of diabetic patients exhibit swollen 
and enlarged mitochondria, implying disturbed mitochondrial morphology under 
diabetic conditions [13].  
The GTPase gene Drp1 is considered pivotal for regulating mitochondrial 
fission [14]. In response to metabolic demand, Drp1 translocates from the cytoplasm 
to the mitochondrial surface where it forms a complex with Fis1. Oligomerization of 
Drp1 provides the mechanical force required to constrict the mitochondrial 
membranes and thereby facilitate fission [15]. Recent studies suggest that Drp1 
recruitment involves post-translational modifications including sumoylation, S-
nitrosylation, ubiquitination, and phosphorylation [16, 17]. Interestingly, Drp1 
activation under glucolipotoxic conditions in pancreatic β-cells leads to abnormalities 
in mitochondrial structure and function, followed by activation of pro-apoptotic 
signaling cascades [18-21]. It has recently been reported that manipulation of 
mitochondrial morphology by overexpressing dominant-negative Drp1 (DN-Drp1) 
with erased GTPase activity decreases GSIS in INS-1E insulinoma cells, and this was 
attributed to increased mitochondrial proton leak [22]. Collectively, these findings 
emphasize the important role of mitochondrial dynamics in pancreatic β-cell biology, 
although exact mechanisms have yet to be established firmly.  
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In the present study, we used genetic and pharmacological inactivation of 
Drp1 to assess mechanistically how mitochondrial dynamics control mitochondrial 
energy transduction and subsequently how this impacts GSIS in MIN6 cells, and 
human and mouse pancreatic islets. We confirm that genetic silencing of the 
mitochondrial fission protein Drp1 by use of lentivirus-mediated shRNA disrupts 
mitochondrial morphology and impairs GSIS in MIN6 cells. We demonstrate that the 
decrease of insulin secretion is secondary to a decreased ATP synthesis instead of 
increased mitochondrial proton leak as suggested previously [22]. We exclude long-
term effects on autophagy and mitochondrial quality control by acute 
pharmacological inactivation of Drp1 with the mitochondrial division inhibitor 
(mdivi-1). Mdivi-1 displays identical attenuating effects on GSIS in mouse and 
human pancreatic islets. Mechanistically, however, comprehensive real-time analysis 
of cellular respiration reveals that the deficient mitochondrial fragmentation lowers 
coupling efficiency of oxidative phosphorylation by decreasing glucose-fuelled 
respiration and not by increasing proton leak. Because Drp1 inhibition did not change 
respiratory complex subunit concentrations, we hypothesized that mitochondrial 
substrate supply may be hampered in fission-deficient pancreatic β-cells. Consistent 
with this, we reveal that direct supply of exogenous (methyl) pyruvate fully rescues 
deficits in oxidative phosphorylation, ATP output and GSIS in fission-deficient cells 
and islets. This discovery of physiologically relevant impairments upstream of 
oxidative phosphorylation offers therapeutic options for treating mitochondrial-
dynamics-related β-cell dysfunction and associated metabolic diseases. 
Research Design and Methods 
Human and mouse islets - Human islets were provided through the JDRF award 31-
2008-416 (ECIT islet for basic research program) and islet experiments were 
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approved by the Ethical Commission of the Technical University of Munich 
(Germany). Mouse islets were isolated by collagenase digestion as previously 
described [23]. For details on islet culturing conditions, refer to supplemental data.  
MIN6 cells and viral infection – For details on cell culture and viral conditions refer 
to supplemental data.  
Insulin secretion from islets – Equal-number batches of islets were washed twice 
with HEPES-balanced Krebs-ringer (KRH) bicarbonate buffer composed of 114 mM 
NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.16 mM MgSO4, 1.2 mM KH2PO4, 25.5 mM 
NaHCO3 and 20 mM HEPES, pH 7.2-7.4, supplemented with 0.2% (w/v) bovine 
serum albumin (BSA) and 2 mM glucose. The islets were starved in the same buffer 
with and without 100 µM mdivi-1 for 1 h at 370C. Later, starvation buffer was 
aspirated and islets were incubated in KRH bicarbonate buffer with indicated 
concentrations of glucose and other secretagogues with and without 100 µM mdivi-1 
for 1 h at 370C. Thereafter, the supernatants were collected, and centrifuged at 760 g 
for 5 min for determination of insulin concentration using a mouse ultrasensitive 
insulin ELISA kit (Alpco). Following the secretion assay, islets were washed twice 
with Dulbecco's PBS, and ice-cold RIPA lysis buffer was added. Islet homogenates 
were collected, centrifuged at 12000 g for 10 min and assayed for total insulin content 
by RIA. For normalization, DNA content was measured using the Quant-it Pico 
Green DNA assay kit (Invitrogen). Each independent experiment was performed with 
three technical replicates. Refer to the supplemental data for details on insulin 
secretion from MIN6 cells. 
Cellular bioenergetics - An extracellular flux analyzer XF24 (Seahorse Bioscience) 
was used to determine oxygen consumption rate (OCR). Cells were seeded into 
XF24-well plates at a density of 40,000 cells/well in DMEM containing 25 mM 
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glucose. The cells were washed twice with bicarbonate-free KRH buffer containing 2 
mM glucose and starved in the same buffer with and without mdivi-1 for 2 h at 370C 
in a non-CO2 incubator. After recording basal cellular respiration, cells were treated 
sequentially with glucose (16.5 mM) and other secretagogues, oligomycin (2 µg/ml), 
and eventually rotenone/antimycin A (1 and 2 µM, respectively) to correct for non-
mitochondrial respiration. Respiration values are presented after correction and 
normalization with DNA content. The respiratory data were analyzed and interpreted 
according to [24]. In short, “basal respiration” represents mitochondrial respiration 
rates at 2 mM glucose, and “ATP linked respiration” represents the respiration rates 
prior to injection of oligomycin minus oligomycin-insensitive rates. Oligomycin-
insensitive rates are labeled “proton leak respiration”. The coupling efficiency 
represents the fraction of respiration used to drive ATP synthesis for each run, 
calculated as CE = 1- (proton leak/respiration prior to oligomycin-injection). 
Islet bioenergetics - Batches of equal numbers of islets were plated into XF24-well 
islet culture plates and washed twice with bicarbonate-free KRH buffer supplemented 
with 2 mM glucose. The islets were starved in the same buffer with and without 100 
µM mdivi-1 for 1 h at 370C in a non-CO2 incubator. The plate was then placed into 
the machine (controlled at 37°C) for a 10-min calibration followed by four 
measurement cycles to record basal cellular respiration. Islets were then treated 
sequentially with glucose (16.5 mM), oligomycin (10 µg/ml), and a mixture of 
rotenone/antimycin A (R/A; both 2 µM). Respiration values were calculated by 
subtracting non-mitochondrial respiration. For normalization, DNA content of the 
cells was measured. 
Intracellular ATP Content - Cells were seeded into white 96-well plates at a density 
of 10,000 cells/well in DMEM containing 25 mM glucose. Cells were treated 
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similarly as for the insulin-secretion assay. At the end of experiment, medium was 
aspirated; cells were washed twice with ice-cold Dulbecco’s PBS and ATP content 
was determined using the Luminescent ATP detection assay kit (Abcam). Results 
were corrected for DNA content. 
Glucose Uptake assay, Western blot analysis and RNA isolation and RT-PCR - 
For details refer to supplemental data.  
Mitochondrial morphology - Mitochondrial morphology was examined in live non-
target and Drp1 KD MIN6 cells stained with 40 nM Mito tracker red FM (Invitrogen) 
for 30 min. After 3-5 washes, cells were examined using a SP5 confocal microscope 
(Leica) with 60X objective lens. 
Statistical analysis - Data were collected from several independent experiments and 
results are expressed as means ± SEM. Unpaired 2-tailed student t-tests were used to 
compare two variables, and one-way ANOVA (with Bonferroni posthoc analysis) was 
used for multiple comparisons using Graph-Pad prism version 6.0. Statistically 
significant differences were considered at p<0.05 (*), p<0.01 (**) and p<0.001 (***). 
Results 
Drp1 knockdown changes mitochondrial morphology and decreases GSIS 
MIN6 cells targeted with specific shRNA express ~50% less Drp1 mRNA (Fig. 1a) 
and 80% less protein (Fig. 1b) than non-targeted control cells. Drp1 knockdown (KD) 
did not affect Mfn1 or Opa1 mRNA levels but caused an increase in Mfn2 mRNA, 
consistent with the concept that mitochondrial elongation is supported (Fig. 1c). 
Moreover, fluorescent visualization of the mitochondrial network revealed elongated 
mitochondria in Drp1 KD cells; i.e., it demonstrated the expected morphological 
changes (Fig. 1d, e). Western analysis of representative subunits from all respiratory 
complexes (gene names are found in Fig. 1f) confirms that Drp1 KD does not affect 
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the composition of the mitochondrial electron-transfer chain (Fig. 1f). Equally, Drp1 
KD leaves the insulin content of MIN6 cells unaffected (Fig. 1g), although it lowered 
Ins2 (not Ins1) mRNA (Fig. 1h).  
Basal insulin release at 2 mM glucose was not affected by Drp1 KD, but insulin 
secretion at 16.5 mM glucose was significantly decreased (Fig. 2a), strongly 
implicating mitochondrial dynamics in the control of nutrient-secretion coupling in 
pancreatic β-cells. Drp1 KD did not affect insulin secretion mechanisms downstream 
of mitochondria, as neither KCl- nor glyburide-provoked insulin release was changed 
(Fig. 2a). In the presence of low glucose levels (2 mM), potassium served to 
depolarize the plasma membrane while glyburide, a sulfonylurea, specifically closes 
ATP-dependent potassium channels. These findings strongly suggest that Drp1 KD 
decreases GSIS through deleterious effects on glucose catabolism. 
Drp1 knockdown lowers coupling efficiency of oxidative phosphorylation 
Real-time oxidative breakdown of glucose can be followed readily in intact cells by 
measuring mitochondrial oxygen uptake utilizing Seahorse technology [25]. Using 
this plate-based respirometry platform, we measured basal respiratory activity of 
MIN6 cells, added glucose to monitor glucose-stimulated respiration, and inhibited 
the ATP synthase with oligomycin to estimate to what extent respiration is used to 
make ATP and how much of it is linked to mitochondrial proton leak. Fig. 2b depicts 
typical oxygen consumption traces, corrected for non-mitochondrial respiration, for 
the entire time course of the respiratory assay. Calculations for (non-) mitochondrial 
respiration, proton leak, ATP-linked respiration and coupling efficiency are described 
in Research Design and Methods. Low-glucose experiments (2 mM) that did not 
require additional glucose during the assay were run in separate wells from high-
glucose (16.5 mM) experiments and were carefully time-matched. Mitochondrial 
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respiration at 2 and 16.5 mM glucose was not significantly different between Drp1 
KD and control cells (Fig. 2c), although glucose-stimulated respiration tended to be 
lower in Drp1 KD cells (Fig. 2c). Interestingly, Drp1 depletion from MIN6 cells 
lowered mitochondrial respiration that is used to make ATP at high glucose (Fig. 2d), 
a statistically significant effect reflected by decreased coupling efficiency of glucose-
stimulated oxidative phosphorylation (Fig. 2e). This relatively low coupling 
efficiency also reflects an increase in mitochondrial proton leak that is provoked by 
Drp1 KD at high glucose (Fig. 2f). Note that the concomitant changes in oxygen 
consumption linked to proton leak (increase) and ATP synthesis (decrease) neutralize 
each other, such that overall glucose-stimulated respiration does not differ 
significantly between Drp1 KD and control cells (Fig. 2c). Since the bioenergetic 
effects of Drp1 depletion are not caused by changes in respiratory chain components 
(suppl. Fig. 1a, b, c), impaired GSIS in the MIN6 cells upon Drp1 KD is thus directly 
related to the decreased rate and coupling efficiency of glucose-stimulated oxidative 
phosphorylation. Consistently, Drp1 KD decreases intracellular ATP content upon 
glucose stimulation by ~ 30% (Fig.  2g).  
Pharmacological Drp1 inhibition corroborates the genetic Drp1 KD phenotype 
Long-term genetic inactivation of Drp1 may well affect mitophagy and mitochondrial 
quality control, which confounds interpretation of Drp1 KD effects on GSIS. Indeed, 
gene expression changes in the Drp1 KD model suggest cellular adaptation (Fig. 1 f, 
k), which is why examined whether acute selective, chemical inhibition of Drp1 that 
recapitulates the reduction of GSIS impairment caused by genetic Drp1 silencing. The 
cell-permeant, small molecule mdivi-1 (mitochondrial division inhibitor-1) inhibits 
Drp1 assembly and GTPase activity and has been previously suggested as a 
therapeutic for stroke, myocardial infarction and neurodegenerative diseases [26-29]. 
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We preincubated MIN6 cells with 25 or 50 µM mdivi-1 at basal and stimulatory 
glucose levels and found that mdivi-1 has no effect on insulin content (Fig. 3a) or 
basal insulin release (Fig. 3b). GSIS, however, is dose-dependently lowered by mdivi-
1, reaching statistical significance at 50 µM (Fig. 3b). These mdivi-1 effects echo 
those observed after Drp1 KD (Fig. 2a). Equally, mdivi-1 fully mimicked the 
bioenergetic effects of Drp1 KD: basal and glucose-stimulated respiration was 
unaffected by 50µM mdivi-1 (Fig. 3c), while mitochondrial proton leak was increased 
(Fig. 3d) and respiration used to make ATP was decreased (Fig. 3e). Consequently, 
mdivi-1 blunts the coupling efficiency of glucose-stimulated oxidative 
phosphorylation (Fig. 3f). Increasing the mdivi-1 dose to 100 µM had no further 
impact on the bioenergetics of the MIN6 cells, suggesting that 50 µM represents the 
fully inhibitory dose (suppl. Fig. 2). To investigate the translational potential of 
fission-dependent GSIS, we incubated human pancreatic islets with mdivi-1 and, 
consistent with the cellular data, observed no effect on insulin content or basal insulin 
release but saw a significant decrease of GSIS (Fig. 4a, b, c). These results 
collectively demonstrate that inhibition of Drp1-mediated mitochondrial fission by 
mdivi-1 controls GSIS in both human pancreatic islets and cultured β-cells. 
Mdivi-1 decreases GSIS in pancreatic islets by decreasing oxidative capacity  
To explore the physiological and pathological relevance of Drp1, we studied the 
effect of mdivi-1 treatment on islets isolated from mice. Consistent with human islet 
and MIN6 cell data, mdivi-1 did not alter insulin content but attenuated GSIS (Fig. 
4d, e, f). Representative real-time respiratory measurements under control conditions 
in islet-capture plates are depicted in Fig. 4g (see Research Design and Methods).  
Mdivi-1 did not affect basal islet respiration at the low glucose concentration but 
significantly lowered glucose-stimulated respiration at the higher concentration (Fig. 
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4h). The lowered respiratory activity at high glucose was due to an mdivi-1-induced 
decrease of respiration linked to ATP synthesis (Fig. 4i), consistent with our results in 
MIN6 cells. Unlike its effect on cells, however, mdivi-1 left islet proton leak 
unaffected (Fig. 4j), which is why its inhibitory effect on ATP-synthesis-coupled 
respiration is apparent from the overall glucose-stimulated oxygen consumption in 
islets (Fig. 4h). Consequent to its lowering effect on glucose oxidation linked to ATP 
synthesis, mdivi-1 significantly decreased the coupling efficiency of mouse islets 
(Fig. 4k). Collectively, these data demonstrate that Drp1 controls islet GSIS by 
regulating glucose oxidation, and not proton leak. 
Pyruvate rescues impaired function of Drp1-deficient cells and islets 
We hypothesized that the impaired glucose oxidation is likely secondary to reduced 
mitochondrial substrate supply, and we assessed this by directly providing pyruvate to 
mitochondria. We observed that the impaired GSIS of Drp1-depleted MIN6 cells 
could be entirely rescued by supplying the cells with exogenous pyruvate (Fig. 5a, b). 
This observation suggests that pyruvate either circumvents defects in glucose-fuelled 
ATP production or else triggers insulin secretion downstream of mitochondria. 
Pyruvate augments glucose-stimulated oxygen uptake in MIN6 cells irrespective of 
the presence of Drp1 (Fig. 5c). The stimulatory effect of pyruvate on glucose 
oxidation was mirrored by a (not statistically significant) boost of GSIS in control and 
Drp1-depleted cells (Fig. 5a). Pyruvate stimulation restores ATP-synthesis-linked 
respiration in Drp1-deficient cells to the level seen in control cells incubated at high 
glucose (Fig. 5d). The restorative effect of pyruvate is not evident from coupling 
efficiency (Fig. 5e), which remained low after pyruvate supplementation because of 
the persistently high mitochondrial proton leak exhibited by Drp1 KD cells (Fig. 5f). 
Pyruvate thus rescues GSIS despite relatively high proton leak activity, demonstrating 
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that GSIS impairment in Drp1-deficient cells is predominantly caused by decreased 
ATP synthesis ability. This conclusion is supported by the increased ATP content in 
pyruvate-treated cells (Fig. 5g, h). The restored ATP levels suggest that glucose-
fueled oxidative phosphorylation in Drp1-deficient MIN6 cells is limited upstream of 
pyruvate; i.e., at the level of glycolysis. Glucose transporter gene expression and 
glucose uptake are not negatively affected in Drp1 KD cells (Fig. 5i, j) and positive 
trends are rather suggesting deficiencies downstream of glucose transport. 
Interestingly, the use of glucokinase activator GKA50 improved glucose oxidation in 
Drp1 KD cells and rescued GSIS (Fig. 5k, l).  
It is difficult to gauge the translational potential of this pyruvate effect as native β-
cells lack the monocarboxylate carrier protein that allows insulinoma cells to take up 
pyruvate [1]. Therefore, we tested the effect of pyruvate supplementation on mouse 
pancreatic islets treated with mdivi-1. GSIS deficiency was not rescued by sodium 
pyruvate in mouse pancreatic islets (Fig. 6a, b), thus excluding the possibility that 
pyruvate acts as an extracellular secretagogue that enhances secretory mechanisms 
downstream of mitochondria. However, GSIS impairment was entirely overcome by 
the membrane-permeant methyl pyruvate (Fig. 6a, b). Indeed, methyl pyruvate is also 
able to provoke insulin secretion in Drp1-inhibited mouse islets in the absence of 
glucose. One-hour incubation with methyl-pyruvate fully rescued the Drp1-dependent 
deficiency of triggered insulin secretion in the presence and absence of 16.5 mM 
glucose (Fig. 6a). The respective respiration measurements indicate that methyl-
pyruvate acts as a mitochondrial substrate by increasing mitochondrial respiration 
(Fig. 6c). Despite some increase in proton leak respiration when glucose and methyl-
pyruvate are combined (Fig. 6d), methyl pyruvate treatment overcomes Drp1-
dependent differences in ATP-synthesis-linked respiration (Fig. 6e). Moreover, the 
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mdivi-1-invoked difference in coupling efficiency is ameliorated by methyl pyruvate 
treatment (Fig. 6f). These findings suggest a model (Fig. 6g) that predicts that direct 
substrate delivery to mitochondria may be pursued as a potential route for drug 
intervention to rescue fission-impaired GSIS. 
Discussion  
The present findings provide important insight into the mechanism by which the 
mitochondrial fission protein Drp1 controls pancreatic insulin secretion. Specifically, 
the data demonstrate that Drp1-mediated mitochondrial fragmentation ensures that 
mitochondria are supplied with sufficient reducing power during GSIS. We 
demonstrate that Drp1 deficiency does not directly impair glucose-stimulated 
oxidative phosphorylation, but instead limits mitochondrial ATP synthesis by 
compromising substrate delivery upstream of mitochondria. Unexpectedly, this 
limitation can be simply overcome by providing β-cells with exogenous pyruvate. 
This insight improves our basic understanding of the relationship between 
mitochondrial dynamics and function [30] as it demonstrates that mitochondrial 
morphology can influence bioenergetic processes (glycolysis) that operate outside and 
upstream from the organelle itself. The ability to rescue impaired mitochondrial ATP 
output by direct substrate delivery opens a new window for the development of 
compounds to treat mitochondrial disorders and, more specifically, defects in insulin 
secretion associated with mitochondrial dysfunction. 
Consistent with previous observations in INS-1E rat insulinoma cells 
overexpressing dominant-negative Drp1 [22], we found that Drp1 deficiency, due 
either to genetic knockdown or pharmacological inhibition, lowers GSIS in MIN6 
mouse insulinoma cells. This Drp1-deficiency phenotype was also exhibited by 
mouse and human pancreatic islets, thus highlighting the physiological and 
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translational relevance of Drp1 control over GSIS.  In agreement with the INS-1E cell 
data [22], we found that Drp1 depletion from MIN6 cells increases mitochondrial 
respiration linked to proton leak and thus lowers coupling efficiency of oxidative 
phosphorylation. However, our plate-based respirometry analysis of adherent MIN6 
cells disclosed that Drp1 KD also causes a decrease of ATP-synthesis-coupled 
respiration, an effect that contributes to the relatively low coupling efficiency in 
Drp1-depleted cells. Our experiments thus demonstrate that Drp1 impacts both 
glucose-fueled respiration used to make ATP and to drive proton leak. In a more 
physiologically relevant experimental model, the pancreatic mouse islet, we further 
found that Drp1 inhibition resulted in marked reduction of ATP-synthesis-linked 
glucose oxidation without having an effect on proton leak. The islet data thus suggest 
that limited glucose-driven respiratory flux is the main explanation for impaired GSIS 
after Drp1 inhibition rather than the increased proton leak that coincides with such 
limitation in cells. Indeed, our ‘substrate rescue’ experiments demonstrate that the 
GSIS defects exhibited by mitochondrial-fission-deficient MIN6 cells can be entirely 
overcome by pyruvate supplementation, despite the persistently elevated proton leak. 
Our data thus provide compelling evidence that glucose-stimulated oxidative 
phosphorylation in mitochondrial-fission-deficient beta cells is largely controlled by 
mitochondrial substrate delivery, as pyruvate supplementation rescues respiration, 
ATP output and insulin secretion, all of which were compromised after Drp1 
silencing. Similarly cell-permeant methyl-pyruvate rescues respiration, coupling 
efficiency and insulin secretion in mdivi-1 treated islets.  Further work, possibly 
involving global metabolomics approaches, is required on the crucial rate-limiting 
steps of substrate supply. Our study excludes compromised glucose availability as 
glucose uptake was increased, not decreased, in Drp1 KD cells. Interestingly, 
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glucokinase activator GKA50 rescued respiration and insulin secretion in MIN6 cells, 
an observation that supports the concept of lowered glucose catabolism but that 
requires experimental confirmation in pancreatic islets. Future studies should also 
consider compromised shuttling of glycolytic NADH to the mitochondrial matrix. 
Although the rescue by pyruvate argues against a role for the mitochondrial pyruvate 
carrier (MPC) during limited substrate supply in Drp1-deficient systems, restricted 
pyruvate transport can also not be formally excluded at this stage. 
Our experiments highlight how modern technologies for measuring cellular 
and islet bioenergetics (such as real-time multi-well-plate-based respirometry) 
improve our understanding of insulin secretion by pancreatic β-cells. Nutrient-
secretion coupling depends to a large degree on the link between glucose catabolism 
and ATP-triggered signaling events that lead to the exocytosis of insulin-containing 
granules. The strength of nutrient-secretion coupling is largely determined by the 
extent to which energy liberated during glucose combustion is used to make ATP, and 
by how much of it is wasted via mitochondrial proton leak. Coupling efficiency of 
oxidative phosphorylation is an often underestimated bioenergetic parameter that is 
highly critical for β-cell biology as it quantifies the proportion of glucose-fueled 
respiration that is coupled to ATP synthesis. As coupling efficiency is an internally 
normalized parameter, it benefits from a comparably high signal-to-noise ratio that 
renders it exquisitely sensitive to any perturbation in proton leak, mitochondrial ATP 
synthesis and/or cellular substrate oxidation [31]. Indeed, changes in coupling 
efficiency following Drp1 silencing underpin our discovery that glycolytic substrate 
delivery to mitochondria is the single parameter that controls insulin secretion, while 
direct effects on energy transduction (proton leak) play a minor role.  
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Other players in the mitochondrial fission-fusion system, such as Opa1 [32], 
also have profound effects on GSIS. Whether or not these effects can be neutralized 
by substrate supplementation or stimulation of fusion genes such as mitofusin (Mfn), 
or if pathological changes in mitochondrial dynamics may more generally be rescued 
by increased substrate delivery, are questions that should be considered for future 
studies. In this respect, it has recently been reported that cellular energy deficiency 
induces mitochondrial fission via AMPK-dependent Fis1 and Drp1 recruitment [33]. 
This fission has been interpreted as being prerequisite for the removal of faulty 
mitochondria by mitophagy [33], but our findings offer the alternative possibility that 
mitochondrial fragmentation enhances glycolytic metabolite delivery to mitochondria 
and thus maintains ATP output during times of high energetic demand. In conclusion, 
mitochondrial dynamics exert profound control over cellular bioenergetics, and while 
influencing mitochondrial activity per se, also affect upstream energetic processes 
such as substrate delivery. 
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Figure legends 
Figure 1. (a, b) Knockdown of Drp1 using lentiviral expression vectors. MIN6 cells 
were infected with non-target vector (black bars) or Drp1 shRNA (white bars) lenti-
virus and selected for stable cell lines. (a) Knockdown efficiency was confirmed by 
qPCR. Data are represented as mean ±SEM (n=3). (b) Immunoblot and quantification 
of Drp1 protein content. Tubulin was used as a loading control (n=4). (c) Relative 
levels of Mfn1, Mfn2 and Opa1 mRNA were measured by RT-qPCR after knockdown 
of Drp1 in MIN6 cells. HPRT was used as a control for each sample. Data are 
represented as mean ±SEM (n=3). (d, e) Live confocal imaging of stably infected 
MIN6 cells that were stained with Mito Tracker red FM for 30 min.  Representative 
confocal images of the non-targeted vector (d) and Drp1 KD cells (e). (f) Immunoblot 
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and densitometric quantification of protein from various oxidative phosphorylation 
subunits in Drp1 KD vs. non-target vector MIN6 cells (n= 3). (g) Insulin content in 
Drp1 KD MIN6 cells measured with Insulin-ELISA. Data are represented as mean 
±SEM (n=4). (h) Relative levels of Ins1 and Ins2 mRNA were measured by RT-qPCR 
after knockdown of Drp1 in MIN6 cells. HPRT was used as a control for each sample. 
Data are represented as mean ±SEM (n=3) and n-values represent independent 
experiments. Statistical significance of mean differences was tested by unpaired 2-
tailed student t-test. P<0.05 (*), P<0.01 (**), P<0.001 (***). 
Figure 2. Glucose-stimulated insulin secretion and bioenergetics of MIN6 cells. 
MIN6 cells stably infected with non-target vector (black bars) and Drp1 shRNA 
(white bars) lenti-virus were exposed to either 2 or 16.5 mM glucose. (a) Insulin 
release was measured after 2 h in the presence of different secretagogues. Data are 
represented as mean ±SEM (n=4). (b) Right panel: Averaged time-resolved oxygen 
consumption traces measured using the XF24 extracellular flux analyzer as described 
in the methods. Left panel: Schematic representation marking different oxygen 
consumption modules. (c) Mitochondrial respiration in response to 2 and 16.5 mM 
glucose. (d) ATP-linked respiration. (e) Coupling efficiency. (f) Proton leak 
respiration and (g) ATP content. Data are represented as mean ±SEM (n=6; n=4 for g) 
and n-values represent independent experiments. Statistical significance of mean 
differences was tested by unpaired 2-tailed student t-test. P<0.05 (*), P<0.01 (**), 
P<0.001 (***).  
Figure 3. Mdivi-1 effects in MIN6 cell culture and human pancreatic islets. (a-f) 
MIN6 cells were exposed to either 2 or 16.5 mM glucose with /without mdivi-1. (a) 
Insulin content at different doses of mdivi-1. (b) Insulin release at different doses of 
mdivi-1. Data are represented as mean ±SEM (n=4). (c) Mitochondrial respiration. (d) 
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Proton leak respiration. (e) ATP-linked respiration and (f) Coupling efficiency. Data 
are represented as mean ±SEM (n=5) and n-values represent independent 
experiments. Statistical significance of mean differences was tested by unpaired 2-
tailed student t-test to compare two variables, and one-way ANOVA (with Bonferroni 
posthoc analysis) was used for multiple comparisons. P<0.05 (*), P<0.01 (**), 
P<0.001 (***). 
Figure 4. Mdivi-1 action on insulin secretion and mitochondrial bioenergetics in 
pancreatic islets. (a-c) Human pancreatic islets were incubated with 2 and 16.5 mM 
glucose with /without mdivi-1. (a) Insulin content, (b) insulin secretion, and (c) 
insulin secretion normalized to insulin content are depicted. (d-k) Mouse pancreatic 
islets: (d-f) Batches of 8 size-matched islets were exposed to either 2 or 16.5 mM 
glucose with/without mdivi-1. After incubation, supernatant and lysates were 
collected for (d) insulin content, (e) insulin secretion, and (f) insulin secretion 
normalized to insulin content. Data are represented as means ±SEM of three 
independent experiments (n=3). (g) Representative scheme of time-resolved oxygen 
consumption traces of mouse wildtype pancreatic islets using islet-capture plates of 
the XF24 extracellular flux analyzer. (h) Mitochondrial respiration at low (2 mM) and 
high (16.5 mM) glucose. (i) ATP-linked respiration. (j) Proton leak respiration and (k) 
Coupling efficiency. Data are represented as means ±SEM (n=5) and n-values 
represent independent experiments. Statistical significance of mean differences was 
tested by unpaired 2-tailed student t-test. P<0.05 (*), P<0.01 (**), P<0.001 (***). 
Figure 5. Pyruvate rescues Drp1-related deficiency in insulin secretion and 
bioenergetics in MIN6 cells. (a-k) MIN6 cells with non-target vector (black bars) 
and Drp1 shRNA (white bars) lenti-virus were exposed to glucose (2 and 16.5 mM) 
or sodium-pyruvate (10 mM) for 2 h. (a) Insulin secretion. (b) Insulin secretion 
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expressed as percentage of non-target vector (control). (c) Mitochondrial respiration. 
(d) ATP-linked respiration. (e) Coupling efficiency. (f) Proton leak respiration. (g) 
Intracelllular ATP content. (h) Intracellular ATP content expressed as percentage of 
non-target vector (control). (i) Relative levels of Glut1, Glut2 and Gck mRNA were 
measured by RT-qPCR in wildtype and Drp1 KD MIN6 cells. HPRT was used as 
housekeeping gene.  (j) Glucose uptake of MIN6 cells. (k-l) Effect of glucokinase 
activator GKA 50 on (k) insulin secretion and (l) oxygen consumption rates. Data are 
represented as means ±SEM (n=4) and n-values represent independent experiments. 
Statistical significance of mean differences was tested by unpaired 2-tailed student t- 
to compare two variables, and one-way ANOVA (with Bonferroni posthoc analysis) 
was used for multiple comparisons. P<0.05 (*), P<0.01 (**), P<0.001 (***). 
Figure 6. Methyl-pyruvate rescues Drp1-related deficiency in insulin secretion 
and bioenergetics in pancreatic mouse islets. (a, b) Batches of eight size-matched 
islets were exposed to different substrates/secretagogues with /without mdivi-1. After 
incubation, supernatant was collected to measure (a) Insulin secretion and (b) Insulin 
secretion normalized to basal control. Data are represented as means ±SEM (n=3). (c) 
Mitochondrial respiration. (d) Proton leak respiration. (e) ATP-linked respiration and 
(f) Coupling efficiency (g) Schematic model of the impact of Drp1 during GSIS, 
emphazising the rescue of insulin secretion with pyruvate. Statistical significance of 
mean differences was tested by unpaired 2-tailed student t- to compare two variables, 
and one-way ANOVA (with Bonferroni posthoc analysis) was used for multiple 
comparisons. P<0.05 (*), P<0.01 (**), P<0.001 (***). 
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Figure 1. (a, b) Knockdown of Drp1 using lentiviral expression vectors. MIN6 cells were infected with non-
target vector (black bars) or Drp1 shRNA (white bars) lenti-virus and selected for stable cell lines. (a) 
Knockdown efficiency was confirmed by qPCR. Data are represented as mean ±SEM (n=3). (b) Immunoblot 
and quantification of Drp1 protein content. Tubulin was used as a loading control (n=4). (c) Relative levels 
of Mfn1, Mfn2 and Opa1 mRNA were measured by RT-qPCR after knockdown of Drp1 in MIN6 cells. HPRT 
was used as a control for each sample. Data are represented as mean ±SEM (n=3). (d, e) Live confocal 
imaging of stably infected MIN6 cells that were stained with Mito Tracker red FM for 30 min.  Representative 
confocal images of the non-targeted vector (d) and Drp1 KD cells (e). (f) Immunoblot and densitometric 
quantification of protein from various oxidative phosphorylation subunits in Drp1 KD vs. non-target vector 
MIN6 cells (n= 3). (g) Insulin content in Drp1 KD MIN6 cells measured with Insulin-ELISA. Data are 
represented as mean ±SEM (n=4). (h) Relative levels of Ins1 and Ins2 mRNA were measured by RT-qPCR 
after knockdown of Drp1 in MIN6 cells. HPRT was used as a control for each sample. Data are represented 
as mean ±SEM (n=3) and n-values represent independent experiments. Statistical significance of mean 
differences was tested by unpaired 2-tailed student t-test. P<0.05 (*), P<0.01 (**), P<0.001 (***).  
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Figure 2. Glucose-stimulated insulin secretion and bioenergetics of MIN6 cells. MIN6 cells stably infected 
with non-target vector (black bars) and Drp1 shRNA (white bars) lenti-virus were exposed to either 2 or 
16.5 mM glucose. (a) Insulin release was measured after 2 h in the presence of different secretagogues. 
Data are represented as mean ±SEM (n=4). (b) Right panel: Averaged time-resolved oxygen consumption 
traces measured using the XF24 extracellular flux analyzer as described in the methods. Left panel: 
Schematic representation marking different oxygen consumption modules. (c) Mitochondrial respiration in 
response to 2 and 16.5 mM glucose. (d) ATP-linked respiration. (e) Coupling efficiency. (f) Proton leak 
respiration and (g) ATP content. Data are represented as mean ±SEM (n=6; n=4 for g) and n-values 
represent independent experiments. Statistical significance of mean differences was tested by unpaired 2-
tailed student t-test. P<0.05 (*), P<0.01 (**), P<0.001 (***).  
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Figure 3. Mdivi-1 effects in MIN6 cell culture and human pancreatic islets. (a-f) MIN6 cells were exposed to 
either 2 or 16.5 mM glucose with /without mdivi-1. (a) Insulin content at different doses of mdivi-1. (b) 
Insulin release at different doses of mdivi-1. Data are represented as mean ±SEM (n=4). (c) Mitochondrial 
respiration. (d) Proton leak respiration. (e) ATP-linked respiration and (f) Coupling efficiency. Data are 
represented as mean ±SEM (n=5) and n-values represent independent experiments. Statistical significance 
of mean differences was tested by unpaired 2-tailed student t-test to compare two variables, and one-way 
ANOVA (with Bonferroni posthoc analysis) was used for multiple comparisons. P<0.05 (*), P<0.01 (**), 
P<0.001 (***).  
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Figure 4. Mdivi-1 action on insulin secretion and mitochondrial bioenergetics in pancreatic islets. (a-c) 
Human pancreatic islets were incubated with 2 and 16.5 mM glucose with /without mdivi-1. (a) Insulin 
content, (b) insulin secretion, and (c) insulin secretion normalized to insulin content are depicted. (d-k) 
Mouse pancreatic islets: (d-f) Batches of 8 size-matched islets were exposed to either 2 or 16.5 mM glucose 
with/without mdivi-1. After incubation, supernatant and lysates were collected for (d) insulin content, (e) 
insulin secretion, and (f) insulin secretion normalized to insulin content. Data are represented as means 
±SEM of three independent experiments (n=3). (g) Representative scheme of time-resolved oxygen 
consumption traces of mouse wildtype pancreatic islets using islet-capture plates of the XF24 extracellular 
flux analyzer. (h) Mitochondrial respiration at low (2 mM) and high (16.5 mM) glucose. (i) ATP-linked 
respiration. (j) Proton leak respiration and (k) Coupling efficiency. Data are represented as means ±SEM 
(n=5) and n-values represent independent experiments. Statistical significance of mean differences was 
tested by unpaired 2-tailed student t-test. P<0.05 (*), P<0.01 (**), P<0.001 (***).  
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Figure 5. Pyruvate rescues Drp1-related deficiency in insulin secretion and bioenergetics in MIN6 cells. (a-k) 
MIN6 cells with non-target vector (black bars) and Drp1 shRNA (white bars) lenti-virus were exposed to 
glucose (2 and 16.5 mM) or sodium-pyruvate (10 mM) for 2 h. (a) Insulin secretion. (b) Insulin secretion 
expressed as percentage of non-target vector (control). (c) Mitochondrial respiration. (d) ATP-linked 
respiration. (e) Coupling efficiency. (f) Proton leak respiration. (g) Intracelllular ATP content. (h) 
Intracellular ATP content expressed as percentage of non-target vector (control). (i) Relative levels of Glut1, 
Glut2 and Gck mRNA were measured by RT-qPCR in wildtype and Drp1 KD MIN6 cells. HPRT was used as 
housekeeping gene.  (j) Glucose uptake of MIN6 cells. (k-l) Effect of glucokinase activator GKA 50 on (k) 
insulin secretion and (l) oxygen consumption rates. Data are represented as means ±SEM (n=4) and n-
values represent independent experiments. Statistical significance of mean differences was tested by 
unpaired 2-tailed student t- to compare two variables, and one-way ANOVA (with Bonferroni posthoc 
analysis) was used for multiple comparisons. P<0.05 (*), P<0.01 (**), P<0.001 (***).  
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Figure 6. Methyl-pyruvate rescues Drp1-related deficiency in insulin secretion and bioenergetics in 
pancreatic mouse islets. (a, b) Batches of eight size-matched islets were exposed to different 
substrates/secretagogues with /without mdivi-1. After incubation, supernatant was collected to measure (a) 
Insulin secretion and (b) Insulin secretion normalized to basal control. Data are represented as means ±SEM 
(n=3). (c) Mitochondrial respiration. (d) Proton leak respiration. (e) ATP-linked respiration and (f) Coupling 
efficiency (g) Schematic model of the impact of Drp1 during GSIS, emphazising the rescue of insulin 
secretion with pyruvate. Statistical significance of mean differences was tested by unpaired 2-tailed student 
t- to compare two variables, and one-way ANOVA (with Bonferroni posthoc analysis) was used for multiple 
comparisons. P<0.05 (*), P<0.01 (**), P<0.001 (***).  
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1. Supplementary figures 
Supplementary figure 1 
 
Supplementary figure 1. MIN6 cells stably infected with non-target vector (black bars) and 
Drp1 shRNA  (white bars) lenti-virus were exposed to 2 and 16.5 mM glucose for 2 h and 
probed for various subunits of the oxidative phosphorylation machinery (OXPHOS). (a) Ponceau 
staining of the Western membrane. (b) Immunoblot of OXPHOS protein detection. A 
representative Western blotting result is depicted. (c) Quantification of expression of OXPHOS 
proteins. Cell lysates (40 µg of protein per lane) were subjected to SDS-PAGE and blotted as 
described in methods (n= 3). Statistical significance of mean differences was tested by unpaired 
2-tailed student t-test. P<0.05 (*), P<0.01 (**), P<0.001 (***). 
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Supplementary figure 2. MIN6 cells were exposed to 2 and 16.5 mM glucose with /without 
mdivi-1 at 50 and 100 µM (a) Mitochondrial respiration (b) Proton leak respiration (c) ATP-
linked respiration and (d) Coupling efficiency. Statistical significance of mean differences was 
tested by One-way ANOVA (Bonferroni) for multiple comparisons. P<0.05 (*), P<0.01 (**), 
P<0.001 (***). 
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Supplementary figure 3. Effect of glucose on mitochondrial fragmentation in cultured MIN6 
cells (a) MIN6 were plated 24 h prior experiment in i-treated ibidi chambers (8- well) at density 
of 70,000 cells/well in DMEM (1g/l glucose), 5% FBS and 1% P/S. Cells were then incubated 
with low glucose (2 mM) and high glucose (16.5 mM) with /without mdivi-1 and loaded with 
MitoTracker Red CMXRos (75 nM).  The cells were washed with PBS and imaged with a Zeiss 
LSM880 Airyscan 63x objective. The images were processed using image analyst MKII 
(www.imageanalyst.net) to filter and binarize the images (2nd/3rd row images). (b) Mean 
mitochondrial length. The morphological pipeline “mean mitochondrial shape parameters” was 
applied to assess mean mitochondrial length of processed images. Average mean mitochondrial 
length is depicted in the bar charts and consists of three viewfields. Values are given as mean ± 
SEM (n = 3). Statistical significance of mean differences was tested by unpaired 2-tailed student 
t-test. P<0.05 (*), P<0.01 (**), P<0.001 (***). 
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Supplementary figure 4 
 
 
 
 
Supplementary figure 4.  GKA50 increases glucose oxidation rates of MIN6 cells. Basal OCR 
rates of MIN6 cells were assessed at 2 mM glucose. Vehicle control, 1 or 25 µM Glucokinase 
activator GKA50 were injected in port A, followed by glucose injection in port B (adjusting 
glucose to 5 mM). Finally, glucose levels were adjusted to 16.5 mM by injection from port C.  In 
port D, rotenone/antimycin A injection served to control for non-mitochondrial respiration. 
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Supplementary figure 5. Effect of pyruvate with/without mdivi-1 on mitochondrial mean length 
in cultured MIN6 cells (a) MIN6 cells were prepared as described in supplementary figure 3 and 
incubated with pyruvate (10 mM) with/without mdivi-1. The untreated low glucose (2 mM) 
condition served as control. Images were obtained and processed as described in supplementary 
figure 3. (b) Mean mitochondrial length. Values are given as mean ± SEM (n = 3).  
 
2. Supplementary experimental procedures 
a. Human and mouse islet culture conditions 
Human islets - Prior to experimentation, human islets (from three different donors) were cultured 
overnight in Connaught Medical Research Laboratories (CMRL) 1066 medium supplemented 
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with 10% human serum, 100 units/ml penicillin, 100 µg/ml streptomycin and 2 mM glutamine 
(Life technologies) at 37°C and 5% CO2. 
 Donar 1 Donar 2 Donar 3 
Date of harvesting  November 4 
2015 5:15 AM 
February 10 2016 
11.45 PM 
October 25 2016 
3.03 AM 
Date of processing November 4 
2015 2:01 PM 
February 11 2016 
11.35 AM 
October 25 2016 
10.50 AM 
Cold ischemic time 06:29 10.25 05:37 
Age 65 55 55 
Gender Female Female Female 
BMI (Kg/m2) 20,8 30,1 24 
ABO blood group O A  
HLA A 3/19 (31) 02/ 2/31(19) 
HLA B 7/18 40/ 18/44(12) 
HLA DR 13/15 13/ 15/15 
HIV I/II Negative  Negative 
HTLV I/II Not done  Not done 
CMV Positive  Positive 
EBV Not done  Not done 
HBsAg Negative  Negative 
Anti-HBc Negative  Negative 
Cause of death Trauma  
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Mouse islets – Male C57BL/6 mice (Janvier Lab) were housed under a 12-h light-dark cycle 
with ad libitum access to food (chow) and water. Mouse islets were incubated overnight in RPMI 
1640 culture medium supplemented with 10% fetal calf serum (Life technologies) at 37°C and 
5% CO2 before experimentation. 
b. MIN6 cell culture and viral infection 
MIN6 cells - MIN6 cells, a pancreatic mouse insulinoma cell line obtained from Prof. J. 
Miyazaki (Osaka University, Japan), were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) with glutaMAX containing 25 mM glucose (Life technologies) supplemented with 
15% heat-inactivated hyclone serum (Thermo scientific), 72 µM 2-mercaptoethanol (Roth), 100 
units/ml penicillin and 100 µg/ml streptomycin (Life Technologies). Cells were incubated at 
37°C in a humidified 5% CO2, 95% air environment. The culture medium was changed every 72 
h and passaged when 80-90% confluent. 
Viral infection - The pre-made lentiviral pLKO.1 control shRNA and mouse Drp1 shRNA 
plasmids were purchased from Sigma. Drp1 shRNA was used to knockdown the expression of 
Drp1 in MIN6 cells. Viral infection was carried out in 96-well plates with 1000 cells/well. After 
24 h of culture, cells were infected with shRNA lentiviral particles to give a Multiplicity Of 
Infection (MOI) of approximately 1. After 24 h of transduction, medium was replaced with 
selection medium containing 1 µg/ml puromycin. The selection was continued until a stable 
puromycin-resistant cell population was obtained. 
c. Insulin secretion from MIN6 cells 
Cells were seeded into 96-well plates at a density of 30,000 cells/well in DMEM containing 25 
mM glucose. After 48 h, the standard culture medium was replaced with fresh medium 
Page 42 of 44Diabetes
containing 5 mM glucose for 16 h. The cells were subsequently washed twice with KRH 
bicarbonate buffer containing 2 mM glucose and starved in the same buffer with and without 
25/50 µM mdivi-1 for 2 h. Later, starvation medium was aspirated, and cells were incubated in 
KRH bicarbonate buffer supplemented with indicated concentrations of glucose and other 
secretagogues with and without 25/50 µM mdivi-1 for 2 h. The amount of insulin secreted and 
total insulin content was assayed using the mouse ultrasensitive insulin ELISA kit. DNA content 
of the cells was measured for normalization. Each independent experiment was performed with 
four technical replicates. 
d. Glucose uptake assay  
MIN6 cells were seeded and preincubated, using the same procedure as those employed for 
determination of insulin secretion. Cells were then incubated with 10 mM glucose and 5 mM 2-
deoxyglucose (2-DG) for 2 h. Later, the medium was removed and cells were washed. 2-DG was 
determined using the calorimetric Glucose Uptake assay kit (Abcam) according to the 
manufacturer’s protocol. Results were corrected for DNA content. 
e. Western blot analysis and RNA isolation and RT-PCR 
 
Western blot analysis - Cells were rinsed with ice-cold Dulbecco’s PBS and incubated with 
RIPA lysis buffer containing a cocktail of protease and phosphatase inhibitors. After sonication 
for 10 sec, cell lysates were centrifuged at 12000 g for 10 min. The protein concentration was 
determined using a BCA protein assay kit (Thermo scientific) according to the manufacturer’s 
protocol. Protein lysates were prepared in Nu-PAGE LDS sample buffer (Novex). Equal 
amounts of total cell protein were separated by 10% or 12% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membrane 
(Bio-Rad). The membranes were blocked for 1 h in TBS-T containing 5% (w/v) BSA at room 
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temperature and then probed overnight at 40C with appropriate primary antibodies: anti-Drp1 
(BD Bioscience), anti-alpha tubulin (Santa Cruz biotechnology) and anti-actin (Cell signaling). 
After three washes with TBS-T, membranes were incubated with respective horse peroxidase-
conjugated secondary antibodies (Santa Cruz biotechnology) for 1 h in TBS-T containing 5% 
(w/v) BSA at room temperature. After three washes with TBS-T, the membranes were detected 
using a chemiluminescence detection system (LI-COR Biosciences). Quantification of band 
density was performed by densitometric analysis and normalized against alpha tubulin and actin 
values. 
RNA isolation and RT-PCR - At the end of experiment, cells were rinsed with ice-cold 
Dulbecco’s PBS and total RNA was extracted using an RNeasy Mini Kit (Qiagen) according to 
the manufacturer’s instructions. RNA concentration and purity were determined using a Nano 
drop spectrophotometer (Thermo scientific). cDNA was synthesized from 1 µg of total RNA 
using a QuantiTect Reverse Transcription Kit (Qiagen) according to the manufacturer’s 
instructions. cDNA was then subjected to real time-PCR using SYBR Green premix (Applied 
Biosystem). HPRT was used as an internal control. Primers used for real time PCR are listed in 
Table 1. 
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f. Primer sequences 
 
 
 
 
 
 
Target genes Forward primer Reverse primer 
DNM1L/ Drp1 TAAGCCCTGAGCCAATCCATC CATTCCCGGTAAATCCACAAGT 
Opa1 TGGAAAATGGTTCGAGAGTCAG CATTCCGTCTCTAGGTTAAAGCG 
Mfn1 CCTACTGCTCCTTCTAACCCA AGGGACGCCAATCCTGTGA 
Mfn2 ACCCCGTTACCACAGAAGAAC AAAGCCACTTTCATGTGCCTC 
INS 1 CACTTCCTACCCCTGCTGG ACCACAAAGATGCTGTTTGACA 
INS 2 GCTTCTTCTACACACCCATGTC AGCACTGATCTACAATGCCAC 
Glut 1 CAGTTCGGCTATAACACTGGTG GCCCCCGACAGAGAAGATG 
Glut 2 TCAGAAGACAAGATCACCGGA GCTGGTGTGACTGTAAGTGGG 
Gck AACGACCCCTGCTTATCCTC CTTCTGCATCCGGCTCATCA 
Page 45 of 44 Diabetes
